Navigation Links
Miracle Treatment for Burn Scars as Seen on Today Show Will Also Be Featured on The Insider Tonight
Date:5/28/2009

NEW YORK, May 28 /PRNewswire/ -- Following the feature of the UltraPulse CO2 fractional laser as a Miracle Treatment for Burn Scars on The Today Show, The Insider will also be featuring the treatment tonight, check your local listings for the time.

Chandra, Jordan and Trae Berns were interviewed today by The Insider. The interview focused on how and when they got their burns they have lived with for 20 years. The girls also discussed their journey through the treatment process with Dr. Jill Waibel, the treating physician. Specifically, they discussed how the Lumenis UltraPulse Laser has helped to minimize both the unwanted color and roughness of their scars. Lastly, they expressed their happiness in the results of the treatments thus far and look forward to additional treatments and results in the next 3 months.

Dr. Jill Waibel was also interviewed for the segment, in which she discussed the fractional treatment she performed on the girls using the Lumenis laser. Specifically, Dr. Waibel talked about the TotalFX, ActiveFX and DeepFX treatments that were used on the girl's burn scars.

Lumenis pioneered skin resurfacing over 18 years ago with its C02 lasers. The Lumenis UltraPulse laser system has FDA clearance for more than 34 indications and is referenced in excess of 90 peer-reviewed publications. Although frequently used for aesthetic applications, the UltraPulse offers 240 watts of power and microsecond pulses which combined provide a broad canvas from which other treatments in cutaneous surgical and aesthetic applications can be provided.

The entire story of the Berns triplets and their treatments using the UltraPulse Fractional CO2 laser can be found at www.bernstriplets.com.

About Lumenis

Lumenis Ltd,. a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for surgical, aesthetic, and ophthalmic applications, is Israel's largest medical device company with more than 800 employees worldwide. The Company invests heavily in R&D and holds a leading position in the markets in which it serves. Lumenis has over 250 patents worldwide, over 75 FDA clearances, worldwide presence in over 100 countries, and an installed base of over 70,000 systems. For more information about Lumenis and its products, log onto www.lumenis.com.

    Contacts: Charly Rok                  Michelle Maydan
              Lippe Taylor                Director of Corporate Communications
              Office: 212-598-4400 x155   Lumenis
              Cell:  917-912-2863         Toll-free: 1-866-569-0597
              charly@lippetaylor.com      Office: +972-4-959-9004
                                          mmaydan@lumenis.com

Lumenis(R) is a registered trademark of Lumenis Ltd.

UltraPulse(R) is a trademark of Lumenis Ltd.

Certain statements and information in this press release may be deemed to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, statements that contain projections of results of operations or of financial condition and all statements (other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. Forward-looking statements are often characterized by the use of forward-looking terminology such as "may," "will," "expect," "anticipate," "estimate," "continue," "believe," "should," "intend," "project" or other similar words, but are not the only way these statements are identified. We have based these forward-looking statements on assumptions and assessments made by our management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments and business decisions to differ materially from those anticipated in these forward-looking statements may be found in our most recent Annual Report on Form 20-F, including the section therein entitled "Risk Factors", as well in our reports on Form 6-K, filed with the Securities and Exchange Commission.


'/>"/>
SOURCE Lumenis Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest
2. Childrens Miracle Network Hospital Doctors On Call to Answer Questions About MRSA Infection
3. Worlds Miracle Baby Turns One
4. Sharing Miracles Television Program Extends Reach Across America: First Episode Features Former White House Press Secretary Tony Snow
5. Round Table Family Charities Raises $350,000 for Childrens Miracle Network
6. Cranberries really are a miracle cure for women
7. Sharing Miracles Television Program to Feature North Carolina State Womens Basketball Coach Kay Yow
8. Sharing Miracles Television Program to Feature Mountain Climber and Cancer Survivor Sean Swarner
9. Sharing Miracles Television Program to Feature Emmy Award-Winning Actor Joey Pantoliano
10. Press Preview to Unveil Miracle Manny
11. The Miracle of Funding by State and Local Pension Plans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... , ... An in-depth computational analysis of genetic variants implicated in both schizophrenia ... that may explain why susceptibility to one of the disorders could place individuals at ... in the journal npj Schizophrenia. , “There is a wealth of genomic data ...
(Date:2/24/2017)... ... February 24, 2017 , ... In the Health Care IT ... top priority because it’s not if you will be attacked, but when.” However, he ... comes to digital health care. , Improvements in auditing and monitoring have taken security ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ ... Erik Schanssema ’s true account of his paramedic experiences. Schanssema describes the tragedies he ... and his attempts to overcome them. , Schanssema, initially unsure of the career path ...
(Date:2/24/2017)... ... February 24, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... Prophecy concerning this present generation. Yisrayl makes an astounding statement when he says ... He explains that the Bible details the current times so plainly that anyone should ...
(Date:2/24/2017)... ... , ... The Radiology Business Management Association will select the 2017 ... Building Better Radiology Marketing Programs conference, held this year from March 5 ... awards are given out in five categories. They are:, ,     Patient ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Feb. 23, 2017  Directors from Pharma To Market ... companies have joined forces, resulting in the founding of Pharma To ... Pharma To Market are pleased to announce their expansion into ... in Singapore . The company are delighted to ... Co-Director of the Singapore based entity. Joelle ...
(Date:2/24/2017)... , Feb. 23, 2017 Non-alcoholic ... on the various drugs being developed for ... all the drugs that are in various ... The pipeline focuses on novel pharmacologic drugs ... stem cell therapies, recombinant proteins and RNA-based ...
(Date:2/24/2017)... STOCKHOLM , Feb 24, 2017 ... Nomination Committee,s proposal for a new Board of Directors ... Meeting. The 2016-2017 Nomination Committee comprises representatives of the ... third quarter of 2016 who have accepted a seat ... Board. The composition of the 2016-2017 Nomination Committee was ...
Breaking Medicine Technology: